Stay updated on Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Sign up to get notified when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.

Latest updates to the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page
- Check6 days agoChange DetectedVersion 10 (2025-11-24) adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other Document Sections; it shows Quality Control Review Not Concluded and Revision: v3.3.2, while Revision: v3.3.1 was removed.SummaryDifference1%

- Check13 days agoChange DetectedThe page history shows a minor revision update from v3.2.0 to v3.3.1; no changes to study details or results are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe notice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check34 days agoChange DetectedThe new screenshot shows the same Record History content with no new entries or status changes; any differences appear to be cosmetic layout/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated status notice and version from v3.1.0 to v3.2.0; page now includes government-operating-status guidance and open-hospital information.SummaryDifference12%

- Check70 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply changes to core content or pricing.SummaryDifference0.3%

Stay in the know with updates to Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.